Page last updated: 2024-10-21

menthol and Hepatocellular Carcinoma

menthol has been researched along with Hepatocellular Carcinoma in 1 studies

Menthol: A monoterpene cyclohexanol produced from mint oils.

Research Excerpts

ExcerptRelevanceReference
"The aim of the present study was to examine changes in the expression and activity of P-glycoprotein (P-gp) in human hepatocellular carcinoma HepG2 cells after exposure to menthol, and their relationship to the cytotoxicity of and apoptotic responses to doxorubicin (DOX), a substrate of P-gp, in the cells."3.96Reduced cytotoxicity in doxorubicin-exposed HepG2 cells pretreated with menthol due to upregulation of P-glycoprotein. ( Fukuno, S; Konishi, H; Miura, T; Nagai, K; Sehara, N; Uchino, Y, 2020)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Nagai, K1
Fukuno, S1
Miura, T1
Uchino, Y1
Sehara, N1
Konishi, H1

Other Studies

1 other study available for menthol and Hepatocellular Carcinoma

ArticleYear
Reduced cytotoxicity in doxorubicin-exposed HepG2 cells pretreated with menthol due to upregulation of P-glycoprotein.
    Die Pharmazie, 2020, 10-01, Volume: 75, Issue:10

    Topics: Antibiotics, Antineoplastic; Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; Car

2020